Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Aug 24, 2022 10:28pm
161 Views
Post# 34918784

RE:RE:NEXT Week

RE:RE:NEXT WeekFWIW, Simply Wall Street has crunched out new numbers to account for q2 results and the financials, fair value is now $1.88 or about 50% higher.

https://simplywall.st/stocks/ca/materials/tsxv-czo/ceapro-shares


Ciao wrote: FWIW, Simply Wall Street just crunches out the numbers and doesn't allocate anything for the pipeline potential of the company, and it is currently giving a fair value of $1.28 / share.  IMHO that's the value they are assiging to the base business. One would expect that fair value to change after Q2 is released.

https://simplywall.st/stocks/ca/materials/tsxv-czo/ceapro-shares#intrinsic-value




<< Previous
Bullboard Posts
Next >>